Cargando…
Oncostatin M is a novel biomarker for coronary artery disease – A possibility as a screening tool of silent myocardial ischemia for diabetes mellitus
OBJECTIVE: Oncostatin M (OSM) is an inflammatory cytokine of the interleukin-6 family which plays a crucial role in the pathogenesis of atherosclerosis. Therefore, we tested our hypothesis that serum OSM levels are increased in patients with coronary artery diseases (CAD). METHODS AND RESULTS: Serum...
Autores principales: | Ikeda, Shohei, Sato, Koichi, Takeda, Morihiko, Miki, Keita, Aizawa, Kentaro, Takada, Tsuyoshi, Fukuda, Koji, Shiba, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250159/ https://www.ncbi.nlm.nih.gov/pubmed/34235245 http://dx.doi.org/10.1016/j.ijcha.2021.100829 |
Ejemplares similares
-
A case of ventricular fibrillation without left ventricular systolic dysfunction induced by trastuzumab emtansine for breast cancer
por: Takeda, Morihiko, et al.
Publicado: (2021) -
Macrophage hypoxia signaling regulates cardiac fibrosis via Oncostatin M
por: Abe, Hajime, et al.
Publicado: (2019) -
Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis
por: Han, Liang, et al.
Publicado: (2023) -
Microvascular dysfunction in silent myocardial ischemia
por: Han, Chih-Lu, et al.
Publicado: (2017) -
Silent Myocardial Ischemia:A challenge for the doctors
por: Wu, Zhoupeng, et al.
Publicado: (2014)